-
Could rewiring the brain’s “brakes” improve movement in Huntington’s disease?
6 min read
Latest News
-
New tool to measure outcomes in Huntington’s Disease clinical trials
6 min read
A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain
-
Huge study reveals new 'genetic modifiers' of Huntington's disease
8 min read
GeM-HD identifies the first solid leads in the hunt for genetic variations that affect Huntington's disease onset
-
Would ewe believe it? GM1, sheep and Huntington's disease
8 min read
HD researchers and sheep farmers are collaborating on a brain fat called GM1, but a clinical trial is a long way off
-
Switching it up: variety in the HD gene affects symptom onset
9 min read
Variety in the HD gene’s on switch affects when symptoms arise.
-
Measuring harmful huntingtin protein in the brain’s bath water
4 min read
How will we know whether HD-lowering treatments are working? New advancements in the detection of mutant huntingtin.
-
A faulty filter? Blood vessel changes in Huntington's disease
7 min read
New research reveals blood vessel changes that could contribute to problem in HD
-
Lighting the way: A new biomarker for Huntington’s disease
7 min read
A new biomarker reveals brain changes in early Huntington's disease.
-
Novel research technique suggests an antioxidant gene protects vulnerable neurons
8 min read
Researchers use a new technique in an HD mouse to uncover a gene, Gpx6, that is protective to vulnerable neurons.
-
Building a Better Mouse(trap): A New Model of Huntington’s Disease
7 min read
New mouse model gives insights into Huntington's disease
-
Taking new targets to the bank: the DNA repair protein ‘ATM’ is overactive in Huntington's disease
6 min read
HD causes the normally helpful protein "ATM" to get a little overzealous. Now we can look for drugs to settle it down
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
